Kezar Life Sciences Inc (KZR) financials · $53.9M cap
Kezar Life Sciences Inc (KZR) $53.9M cap.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $0 | $7.0M | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| Net Income | -$83.7M | -$101.9M | -$68.2M | -$54.6M |
| EPS (Diluted) | $-11.49 | $-14.04 | $-10.13 | $-1.04 |
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | $144.7M | $221.2M | $299.6M |
| Current Assets | $0 | $0 | $0 |
| Cash & Equivalents | $41.7M | $35.5M | $40.5M |
| Inventory | $0 | $0 | $0 |
| PP&E | $0 | $0 | $0 |
| Total Liabilities | $27.8M | $33.7M | $29.7M |
| Current Liabilities | $0 | $0 | $0 |
| Short-term Debt | $0 | $0 | $0 |
| Long-term Debt | $0 | $0 | $0 |
| Total Debt | $0 | $0 | $0 |
| Shareholders' Equity | $0 | $0 | $0 |
| Retained Earnings | $0 | $0 | $0 |
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Operating Cash Flow | -$74.2M | -$81.6M | -$58.8M | -$42.4M |
| CapEx | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $80.4M | $76.0M | -$91.4M | -$28.4M |
| Financing Cash Flow | $103.0K | $638.0K | $127.9M | $112.6M |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Net Change in Cash | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |
FAQ
What is KZR P/E and revenue?
Kezar Life Sciences Inc (KZR) $53.9M cap.
What is KZR revenue?
Kezar Life Sciences Inc last cached revenue is $0 (FY2024).
Is KZR profitable?
Kezar Life Sciences Inc last cached net income is -$83.7M.
What are KZR total assets?
Kezar Life Sciences Inc last cached total assets are $144.7M.
What is KZR free cash flow?
Kezar Life Sciences Inc last cached free cash flow is $0.
Not investment advice. Cached statements, not a live tape.